Owsianka A - Search Results

1

Reverse epitope mapping of the E2 glycoprotein in antibody associated hepatitis C virus.

Naik AS, Owsianka A, Palmer BA, O'Halloran CJ, Walsh N, Crosbie O, Kenny-Walsh E, Patel AH, Fanning LJ. Naik AS, et al. Among authors: owsianka a. PLoS One. 2017 May 30;12(5):e0175349. doi: 10.1371/journal.pone.0175349. eCollection 2017. PLoS One. 2017. PMID: 28558001 Free PMC article.

2

Hepatitis C virus core protein interacts with a human DEAD box protein DDX3.

Owsianka AM, Patel AH. Owsianka AM, et al. Virology. 1999 May 10;257(2):330-40. doi: 10.1006/viro.1999.9659. Virology. 1999. PMID: 10329544 Free article.

3

Evidence for structural differences in the S domain of L in comparison with S protein of hepatitis B virus.

Clayton RF, Owsianka A, Patel AH. Clayton RF, et al. Among authors: owsianka a. J Gen Virol. 2001 Jul;82(Pt 7):1533-1541. doi: 10.1099/0022-1317-82-7-1533. J Gen Virol. 2001. PMID: 11413363

4

Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2.

Owsianka A, Clayton RF, Loomis-Price LD, McKeating JA, Patel AH. Owsianka A, et al. J Gen Virol. 2001 Aug;82(Pt 8):1877-1883. doi: 10.1099/0022-1317-82-8-1877. J Gen Virol. 2001. PMID: 11457993

5

Analysis of antigenicity and topology of E2 glycoprotein present on recombinant hepatitis C virus-like particles.

Clayton RF, Owsianka A, Aitken J, Graham S, Bhella D, Patel AH. Clayton RF, et al. Among authors: owsianka a. J Virol. 2002 Aug;76(15):7672-82. doi: 10.1128/jvi.76.15.7672-7682.2002. J Virol. 2002. PMID: 12097581 Free PMC article.

6

Monoclonal antibody AP33 defines a broadly neutralizing epitope on the hepatitis C virus E2 envelope glycoprotein.

Owsianka A, Tarr AW, Juttla VS, Lavillette D, Bartosch B, Cosset FL, Ball JK, Patel AH. Owsianka A, et al. J Virol. 2005 Sep;79(17):11095-104. doi: 10.1128/JVI.79.17.11095-11104.2005. J Virol. 2005. PMID: 16103160 Free PMC article.

7

Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33.

Tarr AW, Owsianka AM, Timms JM, McClure CP, Brown RJ, Hickling TP, Pietschmann T, Bartenschlager R, Patel AH, Ball JK. Tarr AW, et al. Hepatology. 2006 Mar;43(3):592-601. doi: 10.1002/hep.21088. Hepatology. 2006. PMID: 16496330

8

Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding.

Owsianka AM, Timms JM, Tarr AW, Brown RJ, Hickling TP, Szwejk A, Bienkowska-Szewczyk K, Thomson BJ, Patel AH, Ball JK. Owsianka AM, et al. J Virol. 2006 Sep;80(17):8695-704. doi: 10.1128/JVI.00271-06. J Virol. 2006. PMID: 16912317 Free PMC article.

9

Immunogenic and functional organization of hepatitis C virus (HCV) glycoprotein E2 on infectious HCV virions.

Keck ZY, Xia J, Cai Z, Li TK, Owsianka AM, Patel AH, Luo G, Foung SK. Keck ZY, et al. J Virol. 2007 Jan;81(2):1043-7. doi: 10.1128/JVI.01710-06. Epub 2006 Nov 1. J Virol. 2007. PMID: 17079294 Free PMC article.

10

Cloning, expression, and functional analysis of patient-derived hepatitis C virus glycoproteins.

Tarr AW, Owsianka AM, Szwejk A, Ball JK, Patel AH. Tarr AW, et al. Among authors: owsianka am. Methods Mol Biol. 2007;379:177-97. doi: 10.1007/978-1-59745-393-6_13. Methods Mol Biol. 2007. PMID: 17502679 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters